Autolus Therapeutics's market cap is currently $518.93M. The company's EPS TTM is $-1.208; its P/E ratio is ―; Autolus Therapeutics is scheduled to report earnings on March 11, 2025, and the estimated EPS forecast is $-0.21. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 1.70M	$ 6.19M	$ 2.33M	$ 242.00K	$ 2.91M
Gross Profit	$ -4.87M	$ -131.03M	$ -126.32M	$ -134.65M	$ -1.70M
Operating Income	$ -195.03M	$ -163.78M	$ -164.21M	$ -168.15M	$ -137.86M
EBITDA	$ -156.77M	$ -135.54M	$ -132.01M	$ -160.51M	$ -134.40M
Net Income	$ -208.38M	$ -148.84M	$ -142.10M	$ -142.09M	$ -123.85M
Balance Sheet
Cash & Short-Term Investments	$ 239.57M	$ 382.44M	$ 310.34M	$ 153.30M	$ 210.64M
Total Assets	$ 375.38M	$ 490.27M	$ 405.56M	$ 294.24M	$ 303.53M
Total Debt	$ 52.97M	$ 24.26M	$ 21.00M	$ 54.16M	$ 26.22M
Net Debt	$ -186.60M	$ -358.18M	$ -289.34M	$ -99.14M	$ -184.42M
Total Liabilities	$ 263.91M	$ 191.60M	$ 92.24M	$ 84.20M	$ 48.69M
Stockholders' Equity	$ 111.47M	$ 298.67M	$ 313.32M	$ 210.03M	$ 254.84M
Cash Flow
Free Cash Flow	$ -156.57M	$ -123.15M	$ -126.72M	$ -132.44M	$ -120.15M
Operating Cash Flow	$ -145.59M	$ -112.31M	$ -117.86M	$ -117.76M	$ -101.48M
Investing Cash Flow	$ -10.99M	$ -10.84M	$ -8.86M	$ -14.68M	$ -18.67M
Financing Cash Flow	$ -883.00K	$ 223.61M	$ 284.06M	$ 74.42M	$ 108.86M

Currency in USD

Autolus Therapeutics Earnings and Revenue History

Income Statement >

Autolus Therapeutics Debt to Assets

Balance Sheet >

Autolus Therapeutics Cash Flow

Cash Flow >

Autolus Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing